FDA daily for Monday, February 2, 2026
In this issue: 14 approvals, 8 device recalls and 200 label changes. 2 items touch categories MedGrid carries, and they come first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- FINASTERIDE
TEVA · FINASTERIDE
- Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 2CR Cool Fosy
OCTISALATE, TITANIUM DIOXIDE · Parfums Christian Dior · TOPICAL
Drug and biologic approvals
FDA date:On Mon, Jan 26 FDA approved 9 new applications (1 brand or biologic, 8 generic) and 5 supplements to existing ones.
- CHLORPROMAZINE HYDROCHLORIDE
MSN · CHLORPROMAZINE HYDROCHLORIDE
- TRANEXAMIC ACID
PHARMAZONE · TRANEXAMIC ACID
- BETAMETHASONE DIPROPIONATE
AUROBINDO PHARMA LTD · BETAMETHASONE DIPROPIONATE
- DIFLUPREDNATE
ALEMBIC · DIFLUPREDNATE
- METHYLPREDNISOLONE ACETATE
CAPLIN · METHYLPREDNISOLONE ACETATE
- QUIOFIC
SOLUBIOMIX · FOLIC ACID
- PALIPERIDONE
APOTEX · PALIPERIDONE
- CUPRIC CHLORIDE
AMNEAL · CUPRIC CHLORIDE
- TAPENTADOL HYDROCHLORIDE
NOVITIUM PHARMA · TAPENTADOL HYDROCHLORIDE
- FINASTERIDE
TEVA · FINASTERIDE
Device recalls
FDA date:FDA posted 8 device recalls from 1 firm on Mon, Jan 26.
- Fixone Hybrid Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- Fixone Biocomposite Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- Genesis Screw-In Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- Genesis Dual Thread Screw-In Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- Genesis Knotless Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- Genesis Push-In Suture Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- AlternatiV+ Max Knotless Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
- AlternatiV+ Screw-In Anchor
Aju Pharm Co., Ltd. · Reports of device failure, including anchor breakage, anchor bending, anchor pull out, suture breakage, and secondary packaging breakage.
Label updates
FDA date:200 drug labels took effect on Mon, Jan 19; 1 of the 25 read for this issue is for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.
- Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 2CR Cool Fosy
OCTISALATE, TITANIUM DIOXIDE · Parfums Christian Dior · TOPICAL
- olmesartan medoxomil-hydrochlorothiazide
OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE · AvKARE · ORAL
- Paliperidone
PALIPERIDONE · AvKARE · ORAL
- Valsartan and Hydrochlorothiazide
VALSARTAN AND HYDROCHLOROTHIAZIDE · AvKARE · ORAL
- Valganciclovir hydrochloride for Oral
VALGANCICLOVIR HYDROCHLORIDE · AvKARE · ORAL
- Valganciclovir
VALGANCICLOVIR HYDROCHLORIDE · AvKARE · ORAL
- Bupropion Hydrochloride SR
BUPROPION HYDROCHLORIDE · Radha Pharmaceuticals, Inc. · ORAL
- Pazopanib
PAZOPANIB · AvKARE · ORAL
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.